Recently, there has been an increased focus on improving the quality of drug supply data at EU level, underpinned by a number of policy developments, notably the Council of the European Union's conclusions of 15 November 2013 regarding supply and supply reduction within the implementation of the...

Drug markets can be seen from the perspective of supply and demand. Market-related indicators, therefore, particularly administrative data, such as seizures, price, purity and drug-related offences, are used in most countries for assessment of the drug situation and policy evaluation. However,...

The problem drug use (PDU) indicator is one of the five EMCDDA key epidemiological indicators, addressing key aspects of the prevalence and harms of drug use at the European level. National experts from the PDU network provide prevalence estimates of high-risk drug use by substance and the...

Comparable and reliable data about the number and characteristics of people entering specialised drug treatment in EU Member States is essential for understanding the European drug problem. The EMCDDA has been collecting data on drug treatment entrants through the Treatment demand indicator...

High-risk drug use is one of the major causes of avoidable mortality in Europe, both directly through overdose and indirectly through drug-related diseases, accident, violence and suicide. Drug-related deaths (DRD) is one of the five key epidemiological indicators (KI) of the European Monitoring...

National drug policies address the health and social costs of drug use and the policing and security issues raised by drug production and trafficking. The strategic approach taken by governments needs to respond to problems linked to both established illicit drugs, such as heroin, cocaine and...

At a time of increased debate on the laws controlling the use of cannabis in the European Union, this report answers some of the questions most often asked about cannabis legislation. Using a question and answer format, basic definitions and the obligations of countries under international law...

Rapid communications bring you the latest findings and discussions in key areas in the drugs field. This report provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA drug-related infectious diseases indicator, which collects data on the...

At a time of increased debate on the laws controlling the use of cannabis in the European Union, this report answers some of the questions most often asked about cannabis legislation. Using a question and answer format, basic definitions and the obligations of countries under international law...

National drug policies address the health and social costs of drug use and the policing and security issues raised by drug production and trafficking. The strategic approach taken by governments needs to respond to problems linked to both established illicit drugs, such as heroin, cocaine and...